Inventor
WALSH DAVID A
US59 patents
⚠️ This page may combine multiple inventors who share the name “WALSH DAVID A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROBINS CO INC A H
25 patentsUS4950674AAug 21, 1990
Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment
ROBINS CO INC A H68 citations96
US4810713AMar 7, 1989
Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment
ROBINS CO INC A H54 citations96
US4670566AJun 2, 1987
3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones
ROBINS CO INC A H120 citations96
US4440785AApr 3, 1984
Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation
ROBINS CO INC A H98 citations96
US5273993ADec 28, 1993
Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
ROBINS CO INC A H63 citations95
US5194446AMar 16, 1993
Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals
ROBINS CO INC A H63 citations95
US5070087ADec 3, 1991
Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents
ROBINS CO INC A H90 citations95
US5025031AJun 18, 1991
Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants
ROBINS CO INC A H42 citations92
US4503073AMar 5, 1985
2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids
ROBINS CO INC A H29 citations92
US4313949AFeb 2, 1982
Method of producing an inhibitory effect on blood platelet aggregation
ROBINS CO INC A H36 citations92
US4254146AMar 3, 1981
3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters
ROBINS CO INC A H18 citations82
US4254135AMar 3, 1981
3-Amino-4-hydroxypyrrolidines
ROBINS CO INC A H21 citations81
US5086055AFeb 4, 1992
Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions
ROBINS CO INC A H15 citations74
US5057524AOct 15, 1991
4-[diaryl)hydroxymethyl]-1-piperidinealkylcarboxylic acids, salts and esters useful in the treatment of allergic disorders
ROBINS CO INC A H12 citations74
US4960776AOct 2, 1990
4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
ROBINS CO INC A H8 citations74
US4882330ANov 21, 1989
1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
ROBINS CO INC A H7 citations74
US4585785AApr 29, 1986
Cis and trans-3-aryloxy-4-hydroxypyrrolidines used as anti-arrhythmics
ROBINS CO INC A H8 citations74
US4333951AJun 8, 1982
2-Amino-6-biphenylacetic acids
ROBINS CO INC A H7 citations74
US5061720AOct 29, 1991
Substituted-4-thiazolidinone derivatives
ROBINS CO INC A H17 citations73
US5063235ANov 5, 1991
4-[(diaryl)hydromethyl]-1-piperidinealkanols and esters and carbamates thereof useful in the treatment of allergic disorders
ROBINS CO INC A H2 citations63
US4886794ADec 12, 1989
4-[(α,α-diaryl)-hydroxymethyl]-1-piperidinylalkyl-cyclic carbamate derivatives as allergic response inhibitors
ROBINS CO INC A H6 citations63
US4855448AAug 8, 1989
2-Amino-3-aroyl-γ-oxobenzenebutanoic acids and esters
ROBINS CO INC A H3 citations63
US4452809AJun 5, 1984
Trans-4-(2-chlorophenoxy)-1-ethyl-3-pyrrolidinol and anti-depressant use thereof
ROBINS CO INC A H3 citations63
US4251541AFeb 17, 1981
1-Substituted-3-arylthio-4-hydroxypyrrolidines
ROBINS CO INC A H3 citations63
US4230718AOct 28, 1980
1-Substituted-3,4-epoxypyrrolidines
ROBINS CO INC A H3 citations63
UNITED THERAPEUTICS CORP
11 patentsUS9156786B2Oct 13, 2015
Process to prepare treprostinil, the active ingredient in remodulin®
UNITED THERAPEUTICS CORP44 citations98
US8350079B2Jan 8, 2013
Treprostinil formulation
UNITED THERAPEUTICS CORP66 citations98
US8748657B2Jun 10, 2014
Process to prepare treprostinil
UNITED THERAPEUTICS CORP29 citations96
US9593061B2Mar 14, 2017
Synthesis of intermediates for producing prostacyclin derivatives
UNITED THERAPEUTICS CORP13 citations92
US9593066B2Mar 14, 2017
Process to prepare treprostinil, the active ingredient in remodulin®
UNITED THERAPEUTICS CORP9 citations92
US10322099B2Jun 18, 2019
Process to prepare treprostinil, the active ingredient in remodulin®
UNITED THERAPEUTICS CORP2 citations84
US9604901B2Mar 28, 2017
Process to prepare treprostinil, the active ingredient in Remodulin®
UNITED THERAPEUTICS CORP7 citations84
US11723887B2Aug 15, 2023
Process to prepare treprostinil, the active ingredient in Remodulin®
UNITED THERAPEUTICS CORP2 citations73
US10548863B2Feb 4, 2020
Process to prepare treprostinil, the active ingredient in Remodulin®
UNITED THERAPEUTICS CORP2 citations73
US10478410B2Nov 19, 2019
Process to prepare treprostinil, the active ingredient in Remodulin®
UNITED THERAPEUTICS CORP2 citations73
US11225452B2Jan 18, 2022
Synthesis of intermediates for producing prostacyclin derivatives
UNITED THERAPEUTICS CORP0 citations62
BATRA HITESH
4 patentsUS8497393B2Jul 30, 2013
Process to prepare treprostinil, the active ingredient in Remodulin®
BATRA HITESH86 citations98
US8242305B2Aug 14, 2012
Process to prepare treprostinil, the active ingredient in remodulin
BATRA HITESH79 citations98
US8940930B2Jan 27, 2015
Treprostinil production
BATRA HITESH52 citations97
US8481782B2Jul 9, 2013
Treprostinil production
BATRA HITESH80 citations97
MENTOR O & O INC
2 patentsBIOCRYST PHARM INC
2 patentsILLINOIS TOOL WORKS
2 patentsLAB ENGINEERING & MFG INC
1 patentRANDOL DAVID S
1 patentLUNG BIOTECHNOLOGY PBC
1 patentFUSION INNOVATIONS LLC
1 patentShowing the top 50 of 59 patents by PatentIndex Score.